腫瘤醫療設備市場規模、佔有率和成長分析：按產品類型、癌症類型、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球腫瘤醫療設備市場價值為 1,524.8 億美元，預計到 2025 年將成長至 2033 年的 2,615.8 億美元，在預測期（2026-2033 年）內複合年成長率為 6.18%。

全球腫瘤醫療設備市場涵蓋癌症檢測、治療和後續觀察所需的關鍵設備，例如影像系統和放射治療設備。受癌症發病率上升、人口老化和醫療成本增加的推動，該行業正經歷顯著成長。技術創新正推動市場從基礎X光設備為先進的線性加速器和人工智慧整合診斷解決方案。推動這一擴張的關鍵因素之一是對早期診斷日益成長的需求，這反過來又促進了人們對微創技術的興趣。此外，根據腫瘤基因特徵量身定做的個人化放射治療設備的出現正在革新治療方法。醫院被迫更換過時的設備，並投資於能夠提高精度和減少二次損傷的先進系統。這形成了一個競爭激烈的環境，推動腫瘤醫療設備的進步。

全球腫瘤器材市場促進因素

癌症發生率在各個年齡層的持續上升，推動了對先進診斷和治療設備的穩定需求，促使醫療機構不斷擴大其腫瘤設備供應。為了改善患者預後並最佳化營運效率，醫療系統正在引入尖端的影像、放射治療和外科手術技術。這種持續的需求推動了採購活動的持續發展，並促使製造商開發創新解決方案。隨著醫療服務提供者努力滿足日益成長的患者群體的需求，這些發展正在推動市場的長期成長。此外，人們對早期檢測重要性的認知不斷提高，也為醫療經營團隊的投資策略提供了支持。

全球腫瘤醫療設備市場限制因素

先進腫瘤醫療設備的高成本對醫療服務提供者構成重大挑戰，尤其是在財政拮据的中低收入地區。巨額資本投入的需求延緩了設備更換週期，限制了醫療機構可購買的設備數量，阻礙了創新技術的應用。因此，製造商的銷售成長放緩，醫療機構往往優先考慮基本服務而非高階醫療設備，限制了整體市場發展。此外，資金籌措管道的匱乏常常導致採購決策的拖延，進一步影響市場動態。

腫瘤醫療設備全球市場趨勢

全球腫瘤醫療設備市場正經歷著向人工智慧驅動的個人化影像解決方案的重大轉變。醫療服務提供者正日益利用人工智慧，透過機器學習演算法評估X光影像資料、組織病理切片和臨床病史，從而最佳化每位患者的診斷流程。這種創新方法能夠在早期發現細微的腫瘤特徵，進而實現更精準的分期和個人化的治療方案。因此，多學科團隊在決策和治療選擇方面更有信心，並能夠動態監測治療反應。這一趨勢正在加速人工智慧驅動的腫瘤醫療設備在臨床實踐中的應用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球腫瘤醫療設備市場規模：依產品類型分類

• 診斷設備
• 用於治療的醫療設備
• 外科腫瘤治療設備
• 介入性腫瘤醫療設備
• 支援性醫療設備

全球腫瘤醫療設備市場規模：依癌症類型分類

• 乳癌
• 肺癌
• 結腸癌
• 攝護腺癌
• 婦科癌症
• 血癌
• 腦腫瘤
• 肝癌
• 皮膚癌
• 其他

全球腫瘤醫療設備市場規模：依技術分類

• 放射線治療
• 影像導引腫瘤治療
• 熱消融
• 冷凍消融術
• 電外科
• 機器人輔助腫瘤學
• 以雷射為基礎的腫瘤治療設備
• 其他

全球腫瘤醫療設備市場規模：依應用領域分類。

• 癌症診斷
• 癌症治療
• 腫瘤監測和後續觀察
• 安寧療護

全球腫瘤醫療設備市場規模：依最終用戶分類

• 醫院
• 專科癌症中心
• 門診手術中心
• 診斷影像中心
• 研究和學術機構

全球腫瘤醫療設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Siemens Healthineers AG
• Elekta AB
• Accuray Incorporated
• Becton Dickinson and Company
• Medtronic plc
• Johnson & Johnson
• Stryker Corporation
• Boston Scientific Corporation
• F Hoffmann-La Roche Ltd
• GE HealthCare Technologies Inc
• Koninklijke Philips NV
• Intuitive Surgical Inc
• Olympus Corporation
• Bard Medical
• CR Bard Inc
• AngioDynamics Inc
• Merit Medical Systems Inc
• Theragenics Corporation
• Eckert & Ziegler AG
• IBA Proton Therapy

結論與建議

Global Oncology Devices Market size was valued at USD 152.48 Billion in 2024 and is poised to grow from USD 161.9 Billion in 2025 to USD 261.58 Billion by 2033, growing at a CAGR of 6.18% during the forecast period (2026-2033).

The global oncology devices market encompasses essential tools for cancer detection, treatment, and monitoring, including imaging systems and radiation therapy apparatus. This sector is experiencing significant growth, driven by the rising incidence of cancer, an aging population, and increasing healthcare expenses. Innovations have transformed the landscape from basic X-ray machines to advanced linear accelerators and AI-integrated diagnostic solutions. A critical factor fueling this expansion is the rising demand for early-stage diagnosis, prompting interest in minimally invasive technologies. Additionally, the emergence of personalized radiotherapy devices tailored to tumor genetics is reshaping treatment approaches. Hospitals are compelled to upgrade outdated equipment, investing in advanced systems that enhance precision and reduce collateral damage, thus fostering a competitive environment that incentivizes advancements in oncology devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Devices Market Segments Analysis

Global oncology devices market is segmented by product type, cancer type, technology, application, end user and region. Based on product type, the market is segmented into Diagnostic Devices, Treatment Devices, Surgical Oncology Devices, Interventional Oncology Devices and Supportive Care Devices. Based on cancer type, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Gynecological Cancer, Hematological Cancers, Brain Cancer, Liver Cancer, Skin Cancer and Others. Based on technology, the market is segmented into Radiation Therapy, Imaging-Guided Oncology, Thermal Ablation, Cryoablation, Electrosurgery, Robotic-Assisted Oncology, Laser-Based Oncology and Others. Based on application, the market is segmented into Cancer Diagnosis, Cancer Treatment, Tumor Monitoring & Follow-up and Palliative Care. Based on end user, the market is segmented into Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers, Diagnostic Imaging Centers and Research & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Devices Market

The increasing incidence of cancer among diverse age demographics drives a consistent demand for advanced diagnostic and therapeutic devices, leading healthcare facilities to broaden their oncology equipment offerings. To enhance patient outcomes and optimize operational effectiveness, health systems are embracing cutting-edge imaging, radiotherapy, and surgical technologies. This persistent demand stimulates continuous purchasing activities and inspires manufacturers to develop innovative solutions, fostering long-term market growth as providers strive to meet the needs of a growing patient population. Furthermore, heightened awareness surrounding the importance of early detection bolsters the investment strategies of healthcare administrators.

Restraints in the Global Oncology Devices Market

The high cost associated with advanced oncology devices poses a considerable challenge for healthcare providers, especially in low- and middle-income areas where financial limitations are prevalent. The significant capital investment required can postpone replacement cycles and restrict the quantity of devices that healthcare facilities can buy, hindering the adoption of innovative technologies. As a result, manufacturers experience slower sales growth, and the overall market development is constrained since institutions tend to prioritize essential services rather than investing in high-end medical devices. Additionally, the scarcity of financing solutions often prolongs procurement decisions, further impacting market dynamics.

Market Trends of the Global Oncology Devices Market

The Global Oncology Devices market is experiencing a significant shift towards the integration of AI-driven personalized imaging solutions. Healthcare providers are increasingly leveraging artificial intelligence to refine diagnostic pathways tailored to each patient, utilizing machine-learning algorithms that assess radiographic data, histopathology slides, and clinical histories. This innovative approach facilitates the early detection of subtle tumor signatures, leading to more precise staging and personalized treatment plans. As a result, multidisciplinary teams benefit from improved decision-making and confidence in therapeutic choices, while dynamic monitoring of treatment responses becomes feasible. This trend is propelling widespread adoption of AI-enhanced oncology devices within clinical settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Oncology Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Diagnostic Devices
• Treatment Devices
• Surgical Oncology Devices
• Interventional Oncology Devices
• Supportive Care Devices

Global Oncology Devices Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Gynecological Cancer
• Hematological Cancers
• Brain Cancer
• Liver Cancer
• Skin Cancer
• Others

Global Oncology Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radiation Therapy
• Imaging-Guided Oncology
• Thermal Ablation
• Cryoablation
• Electrosurgery
• Robotic-Assisted Oncology
• Laser-Based Oncology
• Others

Global Oncology Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer Diagnosis
• Cancer Treatment
• Tumor Monitoring & Follow-up
• Palliative Care

Global Oncology Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Cancer Centers
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Research & Academic Institutes

Global Oncology Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Cancer Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Cancer Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Cancer Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Cancer Type, Technology, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Cancer Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bard Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C R Bard Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA Proton Therapy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations